Familial colorectal cancer: Pathology and molecular characteristics

Lancet Oncology

Volumn 1, Issue 4, 2000, Pages 220-226

  Jass, Jeremy R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

COLON POLYPOSIS; COLORECTAL TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PATHOLOGY; PRECANCER; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADENOMATOUS POLYPOSIS COLI; BIOPSY, NEEDLE; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 0034585282     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(00)00152-2     Document Type: Review

References (45)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
2. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 75:1993;1215-1225.
3. Kolodner RD, Tytell JD, Schmeits JL, et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 59:1999;5068-5074.
4. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 368:1994;258-261.
5. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371:1994;75-80.
6. Nelen MR, Padberg GW, Peeters EAJ, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 13:1996;114-116.
7. Marsh DJ, Dahia PLM, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet. 16:1997;333-334.
8. Jass JR, Williams CB, Bussey HJR, et al. Juvenile polyposis - a precancerous condition. Histopathology. 13:1988;619-630.
9. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 280:1998;1086-1088.
10. Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:1998;184-187.
11. Jass JR, Iino H, Ruszkiewicz A, et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut. 47:2000;43-49.
12. Whitelaw SC, Murday VA, Tomlinson IPM, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology. 112:1997;327-334.
13. Tomlinson I, Rahman N, Frayling I, et al. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology. 116:1999;789-795.
14. Bulow S, Burn J, Neale K, et al. The establishment of a polyposis register. Int J Colorect Dis. 8:1993;34-38.
15. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 336:1997;827-832.
16. Talbot IC. Pathology. Phillips RKS, Spigelman AD, Thomson JPS. Familial adenomatous polyposis and other polyposis syndromes. 1994;15-25 Edward Arnold, London.
17. Ballhausen WG. Genetic testing for familial adenomatous polyposis. Ann NY Acad Sci. 910:2000;36-49.
18. Wallace MH, Frayling IM, Clark SK, et al. Attenuated adenomatous polyposis coli. Dis Colon Rectum. 42:1999;1078-1080.
19. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 75:1993;951-957.
20. Laken SJ, Papadopoulos N, Petersen GM, et al. Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA. 96:1999;2322-2326.
21. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutatble tract in APC. Nat Genet. 17:1997;79-83.
22. Vasen HFA, Mecklin J-P, Khan PM, et al. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum. 34:1991;424-425.
23. Vasen HF, Watson P, Mecklin J-P, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 116:1999;1453-1456.
24. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 104:1993;1535-1549.
25. Jass JR. Diagnosis of hereditary non-polyposis colorectal cancer. Histopathology. 32:1998;491-497.
26. Shashidharan M, Smyrk T, Lin KM, et al. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population. Dis Colon Rectum. 42:1999;722-726.
27. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57:1997;4749-4756.
28. Boland CR. Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann NY Acad Sci. 910:2000;50-61.
29. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:1998;5248-5257.
30. Jass JR. Replication error phenotype in colorectal cancer. Gut. 47:2000;597-598.
31. Cawkwell L, Gray S, Murgatroyd H, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut. 45:1999;409-415.
32. Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol. 23:1999;1248-1255.
33. Iino H, Simms LA, Young J, et al. DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut. 47:2000;37-42.
34. Herman JG, Umar A, Polyak K, et al. Incidence andfunctional consequences of hMLH1 promoter hypermethylationin colorectal carcinoma. Proc Natl Acad Sci USA. 95:1998;6870-6875.
35. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence ofhereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 338:1998;1481-1487.
36. Gryfe R, Kim H, Hsieh ETK, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 342:2000;69-77.
37. Biemer-Hüttman A-E, Walsh MD, McGuckin MA, et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res. 6:2000;1909-1916.
38. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 56:1996;4836-4840.
39. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 110:1996;748-755.
40. Jeevaratnam P, Cottier DS, Browett PJ, et al. Familial giant hyperplastic polyposis predisposing to colorectal cancer:a new hereditary bowel cancer syndrome. J Pathol. 179:1996;20-25.
41. Otori K, Oda Y, Sugiyama K, et al. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut. 40:1997;660-663.
42. Rashid A, Houlihan S, Booker S, et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology. 119:2000;323-332.
43. Iino H, Jass JR, Simms LA, et al. DNA microsatellite instabilityin hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol. 52:1999;5-9.
44. Burt R, Jass JR. Hyperplastic polyposis. Hamilton SR, Aaltonen LA. WHO classification of tumours. Pathology and genetics: tumours of the digestive system. 2000;135-136 Springer-Verlag, Berlin.
45. Jass JR, Cottier DS, Pokos V, et al. Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology. 29:1997;28-33.